Approval · Notice of Compliance 18633 · 2016
PRISTIQ: Notice of Compliance 18633
Issued October 17, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18633
- Date
- October 17, 2016
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of A 30 count blister pack
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRISTIQ | Not yet assigned | — |
Medicinal ingredients
- DESVENLAFAXINE SUCCINATE 50 MG per TAB
- DESVENLAFAXINE SUCCINATE 100 MG per TAB